Cargando…

Enrichment and expansion with nanoscale artificial antigen presenting cells for T cell adoptive immunotherapy

Detalles Bibliográficos
Autores principales:	Perica, Karlo, Bieler, Joan, Schuetz, Christian, Varela, Juan, Oelke, Mathias, Schneck, Jonathan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288630/ http://dx.doi.org/10.1186/2051-1426-2-S3-P34

Ejemplares similares

Adoptive T Cell Immunotherapy for Cancer
por: Perica, Karlo, et al.
Publicado: (2015)

Antigen-specific T cell redirectors (ATR) for antigen-specific redirection of T cells to tumors
por: Schütz, Christian, et al.
Publicado: (2014)

Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells
por: Schütz, Christian, et al.
Publicado: (2016)

Correction: Antigen-specific T cell Redirectors: a nanoparticle based approach for redirecting T cells
por: Schütz, Christian, et al.
Publicado: (2018)

HLA-Ig Based Artificial Antigen Presenting Cells for Efficient ex vivo Expansion of Human CTL
por: Chiu, Yen-Ling, et al.
Publicado: (2011)

Killer Artificial Antigen Presenting Cells (KaAPC) for Efficient In Vitro Depletion of Human Antigen-specific T Cells
por: Schütz, Christian, et al.
Publicado: (2014)

Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity
por: Perica, Karlo, et al.
Publicado: (2014)

Wnt pathway activation functionally reprograms human antigen-specific T cells
por: Chiu, Yen-Ling, et al.
Publicado: (2014)

Nanoparticle-based modulation of CD4(+) T cell effector and helper functions enhances adoptive immunotherapy
por: Isser, Ariel, et al.
Publicado: (2022)

Addition of Interleukin-21 for Expansion of T-Cells for Adoptive Immunotherapy of Murine Melanoma
por: Zoon, Christine Kathryn, et al.
Publicado: (2015)

Expansion of T Cells with Interleukin-21 for Adoptive Immunotherapy of Murine Mammary Carcinoma
por: Zoon, Christine K., et al.
Publicado: (2017)

The Basics of Artificial Antigen Presenting Cells in T Cell-Based Cancer Immunotherapies
por: Neal, Lillian R., et al.
Publicado: (2017)

Artificial Antigen Presenting Cells: An Off the Shelf Approach for Generation of Desirable T-Cell Populations for Broad Application of Adoptive Immunotherapy
por: Hasan, AN, et al.
Publicado: (2015)

Ex vivo enrichment of PRAME antigen‐specific T cells for adoptive immunotherapy using CD137 activation marker selection
por: Lee, Koon H, et al.
Publicado: (2020)

Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug
por: Tanaka, Yoshimasa, et al.
Publicado: (2018)

Generation of Antitumor T Cells For Adoptive Cell Therapy With Artificial Antigen Presenting Cells
por: Shrestha, Bishwas, et al.
Publicado: (2020)

Cell Density Plays a Critical Role in Ex Vivo Expansion of T Cells for Adoptive Immunotherapy
por: Ma, Qiangzhong, et al.
Publicado: (2010)

Induction/Engineering, Detection, Selection, and Expansion of Clinical-Grade Human Antigen-Specific CD8(+) Cytotoxic T Cell Clones for Adoptive Immunotherapy
por: Jeras, Matjaž, et al.
Publicado: (2010)

Genetically modified artificial antigen-presenting cells (aAPC) for expansion of melanoma tumor infiltrating lymphocytes with optimal properties for adoptive cell therapy
por: Forget, Marie-Andrée, et al.
Publicado: (2013)

Fully automated expansion and activation of clinical-grade natural killer cells for adoptive immunotherapy
por: GRANZIN, MARKUS, et al.
Publicado: (2015)

Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy
por: YOSHIKAWA, TOSHIAKI, et al.
Publicado: (2014)

Optimizing interleukin-2 concentration, seeding density and bead-to-cell ratio of T-cell expansion for adoptive immunotherapy
por: Ghaffari, Sasan, et al.
Publicado: (2021)

Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells
por: Kirkin, Alexei F., et al.
Publicado: (2018)

Combined PD-L1 and TIM3 blockade improves expansion of fit human CD8(+) antigen-specific T cells for adoptive immunotherapy
por: Lak, Shirin, et al.
Publicado: (2022)

Decline of influenza-specific CD8(+ )T cell repertoire in healthy geriatric donors
por: Lee, Jessica B, et al.
Publicado: (2011)

Nanoscale imaging of E. coli cells by expansion microscopy
por: Cheng, Sharey, et al.
Publicado: (2019)

MHC-Ig induces memory T cell formation in vivo and inhibits tumour growth
por: Schütz, Christian, et al.
Publicado: (2014)

Artificial Nanoscale Erythrocytes from Clinically Relevant Compounds for Enhancing Cancer Immunotherapy
por: Ou, Wenquan, et al.
Publicado: (2020)

Immunotherapy: ADOPTIVE T CELL IMMUNOTHERAPY FOR SARS-COV-2
por: Henden, A., et al.
Publicado: (2023)

Adoptive Immunotherapy beyond CAR T-Cells
por: Titov, Aleksei, et al.
Publicado: (2021)

Langerhans dendritic cell vaccine bearing mRNA-encoded tumor antigens induces antimyeloma immunity after autotransplant
por: Chung, David J., et al.
Publicado: (2022)

Nanoscale Imaging of RNA with Expansion Microscopy
por: Chen, Fei, et al.
Publicado: (2016)

Ex vivo expansion of human T cells for adoptive immunotherapy using the novel Xeno-free CTS Immune Cell Serum Replacement
por: Smith, Corey, et al.
Publicado: (2015)

Artificial Antigen Presenting Cell (aAPC) Mediated Activation and Expansion of Natural Killer T Cells
por: East, James E., et al.
Publicado: (2012)

Large Scale Ex Vivo Expansion of γδ T cells Using Artificial Antigen-presenting Cells
por: Boucher, Justin C., et al.
Publicado: (2023)

Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy
por: Garcia-Aponte, Oscar Fabian, et al.
Publicado: (2021)

Natural killer cells in antitumour adoptive cell immunotherapy
por: Laskowski, Tamara J., et al.
Publicado: (2022)

Trial Watch: Adoptive cell transfer immunotherapy
por: Galluzzi, Lorenzo, et al.
Publicado: (2012)

Synthetic immunology: T-cell engineering and adoptive immunotherapy
por: Si, Wen, et al.
Publicado: (2018)

Adoptive Immunotherapy for Hematological Malignancies Using T Cells Gene-Modified to Express Tumor Antigen-Specific Receptors
por: Fujiwara, Hiroshi
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_e27m0qf70dc74t3uudc6a0vdkm